Key facts
- Upperline Health’s last known valuation is $120.8M (Dec 2021).
- It has raised $106.3M across 2 recorded rounds; the latest was Early Stage VC ($14.0M) in Feb 2020.
- Notable investors include Silversmith Capital Partners, Adam Boehler, Crestline Investors, Rare Capital.
- Upperline Health has filed 3 Form Ds with the SEC since 2018, most recently Apr 2021 ($14.0M sold to 6 investors).
- Status: Acquired/Merged (Operating Subsidiary).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Upperline Health
Funding rounds
2 roundsAbout Upperline Health
Provider of specialty practices intended to help comprehensive chronic care through frequent specialist visits. The company's mission is to transform how specialists engage with patients and partner with PCPs, payers and other providers to improve patient care, engaging patients with polychronic conditions who can benefit from better care coordination via an interdisciplinary team.
- Sector
- Healthcare
- HQ
- Nashville, TN, United States
- Founded
- 2017
- Employees
- 1,500
- Website
- upperlinehealth.com/
- Ownership
- Acquired/Merged (Operating Subsidiary)
Upperline Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Upperline Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Upperline Health in its N-PORT filings yet. We sweep new filings monthly.